Acquired thrombocytosis (Q39445): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Neoplasia mieloproliferativa crônica que inclui primariamente a linhagem megacariocítica. É caracterizada por trombocitose sustentada no sangue, aumento do número de megacariócitos grandes e maduros na medula óssea e episódios de trombose e/ou hemorragia. Progressão para um estágio de mielofibrose pós-trombocitemia essencial ou transformação para leucemia aguda é observada raramente. | |||||||||||||||
| description / en | description / en | ||||||||||||||
A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterised by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or haemorrhage. Progression to a post essential thrombocythaemia myelofibrosis stage or transformation to acute myeloid leukaemia is rarely observed. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1744773503 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:3B63.1 | |||||||||||||||
| Property / CURIE: CID11:3B63.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-3B63.1 | |||||||||||||||
| Property / Canary Token: dki-india-3B63.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: D47.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 04:52, 13 August 2026
A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterised by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or haemorrhage. Progression to a post essential thrombocythaemia myelofibrosis stage or transformation to acute myeloid leukaemia is rarely observed.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 3B63.1 |
||
| English | Acquired thrombocytosis |
A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterised by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or haemorrhage. Progression to a post essential thrombocythaemia myelofibrosis stage or transformation to acute myeloid leukaemia is rarely observed. |
Statements
CID11:3B63.1
0 references
dki-india-3B63.1
0 references
Concluído
0 references
13 August 2026
0 references
